In this episode we evaluate the IMpassion130 trial on the use of atezolizumab in triple-negative breast cancer. We also interview Dr. Brian Chan of OHSU on a randomized controlled trial he's running that tests whether Dr. Gawande's idea of "hot-spotting" -- tailoring interventions to medically complex patients -- does decrease hospitalizations.
IMpassion130: doi.org/10.1056/NEJMoa1809615
Hot-spotting: https://www.newyorker.com/magazine/2011/01/24/the-hot-spotters

In this episode we evaluate the IMpassion130 trial on the use of atezolizumab in triple-negative breast cancer. We also interview Dr. Brian Chan of OHSU on a randomized controlled trial he's running that tests whether Dr. Gawande's idea of "hot-spotting" -- tailoring interventions to medically complex patients -- does decrease hospitalizations. IMpassion130: doi.org/10.1056/NEJMoa1809615 Hot-spotting: https://www.newyorker.com/magazine/2011/01/24/the-hot-spotters

1.18 IMpassion130 and Hot-Spotting with Dr. Brian Chan

Dr Prasad currently serves as the Director of the Center for Biologics Evaluation and Resesarch (CBER) at the US FDA. The audio on this platform were posted before my FDA employment and do not necessarily represent the views of the FDA or the United States. This site will be inactive during my federal service.

A podcast on medicine, oncology, & health policy. 
Host: Vinay Prasad, MD MPH from University of California San Francisco.
Tweet your feedback to @Plenary_Session or e-mail plenarysessionpodcast@gmail.com

Medicine

Dr Prasad currently serves as the Director of the Center for Biologics Evaluation and Resesarch (CBER) at the US FDA. The audio on this platform were posted before my FDA employment and do not necessarily represent the views of the FDA or the United States. This site will be inactive during my federal service. A podcast on medicine, oncology, & health policy. Host: Vinay Prasad, MD MPH from University of California San Francisco. Tweet your feedback to @Plenary_Session or e-mail plenarysessionpodcast@gmail.com

Dr Prasad currently serves as the Director of the Center for Biologics Evaluation and Resesarch (CBER) at the US FDA. The audio on this platform were posted before my FDA employment and do not necessarily represent the views of the FDA or the United States. This site will be inactive during my federal service.

A podcast on medicine, oncology, &amp; health policy. 
Host: Vinay Prasad, MD MPH from University of California San Francisco.
Tweet your feedback to @Plenary_Session or e-mail plenarysessionpodcast@gmail.com

Share 1.18 IMpassion130 and Hot-Spotting with Dr. Brian Chan

Sign up to save your podcasts

1.18 IMpassion130 and Hot-Spotting with Dr. Brian Chan

1.18 IMpassion130 and Hot-Spotting with Dr. Brian Chan

More shows like Plenary Session - inactive due to federal service

Freakonomics Radio

Pivot

The Daily

The ZDoggMD Show

The Diary Of A CEO with Steven Bartlett

The Readout Loud

The Peter Attia Drive

Buried Bones - a historical true crime podcast with Kate Winkler Dawson and Paul Holes

The Charlie Kirk Show

All-In with Chamath, Jason, Sacks & Friedberg

Oncology Today with Dr Neil Love

SmartLess

The Megyn Kelly Show

The VPZD Show

Sensible Medicine